Sonoma Pharmaceuticals, Inc. (SNOA) Q1 2024 Annual Earnings
SNOA·Reported June 17, 2024·Before market open
Sonoma Pharmaceuticals, Inc. reported Q1 2024 revenue of $3.4M, missed analyst consensus of $4.0M by $541.0K. Diluted EPS came in at $-1.40, beat the $-3.41 consensus by $2.01.
Revenue
$3.4Mmissed by $541.0K
Consensus: $4.0MDiluted EPS
$-1.40beat by $2.01
Consensus: $-3.41
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Sonoma Pharmaceuticals, Inc.'s Q1 2024 earnings report.
Sonoma Pharmaceuticals, Inc. (SNOA) reported Q1 2024 earnings on June 17, 2024 before market open.
Sonoma Pharmaceuticals, Inc. reported revenue of $3.4M and diluted EPS of $-1.40 for Q1 2024.
Revenue missed the consensus estimate of $4.0M by $541.0K. EPS beat the consensus estimate of $-3.41 by $2.01.
You can read the 10-K periodic report (0001683168-24-004275) directly on SEC EDGAR. The filing index links above go to sec.gov.